Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3114416
Max Phase: Preclinical
Molecular Formula: C15H26ClN
Molecular Weight: 219.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3114416
Max Phase: Preclinical
Molecular Formula: C15H26ClN
Molecular Weight: 219.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCc1cccc(CCCC)c1CN.Cl
Standard InChI: InChI=1S/C15H25N.ClH/c1-3-5-8-13-10-7-11-14(9-6-4-2)15(13)12-16;/h7,10-11H,3-6,8-9,12,16H2,1-2H3;1H
Standard InChI Key: PBDWDTKKWFPSLF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 219.37 | Molecular Weight (Monoisotopic): 219.1987 | AlogP: 3.83 | #Rotatable Bonds: 7 |
Polar Surface Area: 26.02 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.29 | CX LogP: 4.79 | CX LogD: 2.92 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.74 | Np Likeness Score: 0.12 |
1. Lucchesini F, Pocci M, Alfei S, Bertini V, Buffoni F.. (2014) Synthesis of 2,6-disubstituted benzylamine derivatives as reversible selective inhibitors of copper amine oxidases., 22 (5): [PMID:24529308] [10.1016/j.bmc.2014.01.037] |
Source(1):